This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Tilray (TLRY) to Report Q2 Earnings: What's in the Cards?
by Zacks Equity Research
Investors will focus on revenue growth and other pipeline updates, when Tilray (TLRY) reports second-quarter 2020 results.
Will Tilray, Inc. (TLRY) Report Negative Earnings Next Week? What You Should Know
by Zacks Equity Research
Tilray, Inc. (TLRY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Tilray, Inc. (TLRY) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Tilray, Inc. (TLRY) closed at $7.38 in the latest trading session, marking a -1.99% move from the prior day.
Are Options Traders Betting on a Big Move in Tilray (TLRY) Stock?
by Zacks Equity Research
Investors need to pay close attention to Tilray (TLRY) stock based on the movements in the options market lately.
Are Options Traders Betting on a Big Move in Tilray (TLRY) Stock?
by Zacks Equity Research
Investors need to pay close attention to Tilray (TLRY) stock based on the movements in the options market lately.
Cannabis ETF Tops in May: 5 Stocks That Led The Way
by Sweta Killa
Inside the best performing stocks in the top cannabis ETF of May.
Tilray (TLRY) Catches Eye: Stock Jumps 6.3%
by Zacks Equity Research
Tilray (TLRY) saw a big move last session, as its shares jumped more than 6% on the day, amid huge volumes.
Tilray Inc (TLRY) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
Tilray Inc (TLRY) delivered earnings and revenue surprises of -11.36% and 4.85%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Are Marijuana Stocks, ETFs Poised for Upbeat Earnings?
by Sanghamitra Saha
"Essential Business" status tagged with marijuana selling amid lockdowns should have helped cannabis stocks and ETFs in the first quarter.
Tilray, Inc. (TLRY) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Tilray, Inc. (TLRY) closed the most recent trading day at $7.41, moving +0.27% from the previous trading session.
Tilray (TLRY) to Report Q1 Earnings: What's in the Cards?
by Zacks Equity Research
Investors will focus on revenue growth and other pipeline updates, when Tilray (TLRY) reports first-quarter 2020 results.
Is the Options Market Predicting a Spike in Tilray (TLRY) Stock?
by Zacks Equity Research
Investors need to pay close attention to Tilray (TLRY) stock based on the movements in the options market lately.
Tilray, Inc. (TLRY) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Tilray, Inc. (TLRY) closed the most recent trading day at $8.07, moving +0.25% from the previous trading session.
Tilray, Inc. (TLRY) Stock Moves -1.18%: What You Should Know
by Zacks Equity Research
In the latest trading session, Tilray, Inc. (TLRY) closed at $6.68, marking a -1.18% move from the previous day.
Tilray (TLRY) in Focus: Stock Moves 9.6% Higher
by Zacks Equity Research
Tilray (TLRY) saw a big move last session, as its shares jumped nearly 10% on the day, amid huge volumes.
Are Marijuana Stocks & ETFs Coronavirus-Proof?
by Sanghamitra Saha
Marijuana companies are witnessing robust demand amid the coronavirus outbreak. Time to buy some earlier-battered marijuana stocks and ETFs?
Do Options Traders Know Something About Tilray (TLRY) Stock We Don't?
by Zacks Equity Research
Investors need to pay close attention to Tilray (TLRY) stock based on the movements in the options market lately.
Company News for Mar 4, 2020
by Zacks Equity Research
Companies in the news are: SCON, OMER, QGEN, TLRY
Tilray, Inc. (TLRY) Reports Q4 Loss, Misses Revenue Estimates
by Zacks Equity Research
Tilray, Inc. (TLRY) delivered earnings and revenue surprises of -82.35% and -15.20%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
Tilray (TLRY) to Report Q4 Earnings: What's in the Cards?
by Zacks Equity Research
Investors will focus on revenue growth and other pipeline updates, when Tilray (TLRY) reports fourth-quarter 2019 results.
Implied Volatility Surging for Tilray (TLRY) Stock Options
by Payel Dhar
Investors need to pay close attention to Tilray (TLRY) stock based on the movements in the options market lately.
What Do Canopy Earnings Say About Cannabis ETFs?
by Sanghamitra Saha
Solid earnings drive Canopy Growth stock and boost the industry as a result. Is it right time to buy marijuana ETFs?
Tilray, Inc. (TLRY) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Tilray, Inc. (TLRY) closed at $17.78 in the latest trading session, marking a +1.08% move from the prior day.
Zacks Market Edge Highlights: Amazon, Tesla, Beyond Meat, Ferrari and Tilray
by Zacks Equity Research
Zacks Market Edge Highlights: Amazon, Tesla, Beyond Meat, Ferrari and Tilray
Tesla Euphoria: Signal of a Market Top?
by Tracey Ryniec
With Tesla price targets flying high, some investors are having flashbacks to analyst upgrades on Amazon in 1998 that signaled an overheated stock market.